|
2025
|
Invention
|
An imidazole-indole derivative binding to 5-ht7 serotonin receptor, a pharmaceutical composition ... |
|
2024
|
Invention
|
Bispecific anti-axl and anti-pd-l1 antibodies and their use in therapy, particularly in the treat... |
|
2023
|
Invention
|
Novel ionizable lipid compounds for nucleic acid delivery.
Novel ionizable lipid compounds, comp... |
|
|
Invention
|
Novel ionizable lipid compounds for nucleic acid delivery |
|
|
Invention
|
Novel ionizable lipid compounds for nucleic acid delivery. Novel ionizable lipid compounds, compo... |
|
2022
|
Invention
|
Human fibroblast growth factor 1 (fgf-1) muteins, their dimers and uses.
The present invention r... |
|
|
Invention
|
Human fibroblast growth factor 1 (fgf-1) muteins, their dimers and uses. The present invention re... |
|
2019
|
Invention
|
Ketamine composition for use in a method of treatment of depression by pulmonary administration. ... |
|
|
Invention
|
An inhaler for electronically supervised parenteral administration of a pharmaceutical compositio... |
|
|
Invention
|
Electronically supervised administration of a pharmaceutical composition.
A system for electroni... |
|
|
Invention
|
Electronically supervised administration of a pharmaceutical composition. A system for electronic... |
|
|
Invention
|
3-phenyl-4-hexynoic acid derivatives as gpr40 agonists. A compound of the formula (I) wherein R r... |
|
|
Invention
|
3-phenyl-4-hexynoic acid derivatives as gpr40 agonists. A compound of the formula (I)wherein R re... |
|
2018
|
Invention
|
Dry powder ketamine composition for use in the treatment of depression by pulmonary administratio... |
|
|
Invention
|
Pyrazole[1,5-a] pyrimidine derivatives as kinase jak inhibitors. 2, halogen, alkyl C1-C4, alkoxyl... |
|
|
Invention
|
Pyrazolo[1,5-a]pyrimidine derivatives as kinase jak inhibitors. A compound or its acid addition s... |
|
|
Invention
|
Pyrazole[1,5-a]pyrimidine derivatives as kinase jak inhibitors. A compound or its acid addition s... |
|
2017
|
Invention
|
Isoindoline derivatives for the treatment of cns diseases. A compound of the formula (I) wherein ... |
|
2016
|
Invention
|
7-(morpholin-4-yl)pyrazole[1,5-a]pyrimidine derivatives as pi3 kinase inhibitors. 2, and their ph... |
|
|
Invention
|
7-(morpholin-4-yl)pyrazole[1,5-a]pyrimidine derivatives which are useful for the treatment of imm... |
|
2015
|
Invention
|
Fused triazole derivatives as phosphodiesterase 10a inhibitors. 3), A represents unsubstituted or... |
|
|
Invention
|
Fused triazole derivatives as phosphodiesterase 10a inhibitors. Disclosed are selected comp... |
|
|
Invention
|
Fused triazole derivatives as phosphodiesterase 10a inhibitors. Compounds of the general formula ... |
|
|
Invention
|
Pyrazolo[1,5-a]pyrimidine derivatives as kinase jak-2 inhibitors. A compound of the general formu... |
|
2014
|
Invention
|
Pyrazolylbenzo[d]imidazole derivatives. 3 together with nitrogen atom to which they are both atta... |
|
|
Invention
|
Pyrazolylbenzo[d]imidazole derivatives. A compound represented by the general Formula (I), wherei... |
|
|
Invention
|
Label for an inhaler |
|
|
Invention
|
Inhaler |
|
2013
|
Invention
|
Pyrazolo[4,3-d]pyrimidin-7(6h)-one derivatives as pde9 inhibitors. Pyrazolo[4,3-d]pyrimidin-7(6H)... |
|
|
Invention
|
Imidazo[1,2-b]pyridazin-6-amine derivatives as kinase jak-2 inhibitors. A compound represented by... |
|
|
Invention
|
Pyrazolo[3,4-d]pyrimidin-4(5h)-one derivatives as pde9 inhibitors. A compound of the general form... |
